Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab

November 6, 2017 โ€“ Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found no ...

Home November 06, 2017
Home
Technology | Advanced Visualization

November 6, 2017 โ€” TeraRecton announced the launch of version 4.4.13 of its iNtuition advanced visualization platform ...

Home November 06, 2017
Home
News | Heart Valve Technology

November 6, 2017 โ€” One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign System ...

Home November 06, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 6, 2017 โ€” The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months in ...

Home November 06, 2017
Home
News | FFR Technologies

November 6, 2017 โ€” Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 6, 2017 โ€” Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents ...

Home November 06, 2017
Home
News | Cardiac Imaging

November 6, 2017 โ€“ The Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory Payment ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 3, 2017 โ€” Biotronik's Orsiro drug-eluting stent (DES) demonstrated high long-term safety and clinical ...

Home November 03, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 3, 2017 โ€” A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests statins are ...

Home November 03, 2017
Home
The Abbott/St. Jude Confirm RX implantable cardiac monitor (ICM) is the first ICM that is compatible with patients' smartphones to eliminate the need for a bedside base unit monitor to transfer data to physicians. Its FDA clearance was in October 2017.
Feature | Dave Fornell

November 3, 2017 โ€” Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...

Home November 03, 2017
Home
News | Wearables

November 3, 2017 โ€” VitalConnect Inc. announced the fourth and final Series C closing, bringing the total Series C round ...

Home November 03, 2017
Home
Technology | FFR Technologies

Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist RXi Mini System, the next-generation system of its RXi Rapid Exchange FFR System. The RXi Mini System debuted at the 29th Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Oct. 29-Nov. 2 in Denver.

Home November 03, 2017
Home
The Watchman LAA occluder PREVAIL Trial 5-year results were presented at the 2017 TCT meeting.
Feature | Atrial Fibrillation

November 2, 2017 โ€“ Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the ...

Home November 02, 2017
Home
The B. Braun Sequent Please drug-eluting balloon.
Feature | Drug-Eluting Balloons

November 2, 2017 โ€” The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (Drug ...

Home November 02, 2017
Home
News | Chronic Total Occlusion (CTO)

November 2, 2017 โ€” Crossing the occlusion with a guidewire is often the most challenging part of chronic total occlusion ...

Home November 02, 2017
Home
Subscribe Now